Sign InBreakout Stocks of Week 25 @ OTCMKTS
NASDAQ was up last week (week 24) by 0.698% ending at 25,888.84 points after gaining 179.41 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Geovax Labs Inc OTCMKTS:GOVX. This stock has had a buy signal since Jun 09, 2026 when the price was $1.28 , but have so far fallen -4.69% to $1.22. Some other companies are on our watchlist to, among these are which all got a breakout pattern emerging.
| Date | Company | Price | Week 25 |
|---|---|---|---|
| Geovax Labs Inc | $1.22 | $1.34 | 9.84% |
The Geovax Labs stock price gained 3.39% on the last trading day (Friday, 12th Jun 2026), rising from $1.18 to $1.22. During the last trading day the stock fluctuated 25.64% from a day low at $1.17 to a day high of $1.47. The price has fallen in 8 of the last 10 days and is down by -40.78% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $4.33 million.
On May 19, 2026, it was reported that Noble Capital Markets gave GOVX a "Outperform" grade with a "hold" action.
The Geovax Labs stock holds several negative signals and despite the positive trend, we believe Geovax Labs will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Geovax Labs Inc:
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
IIIV
$20.09
|
5.03% | Jun 25 |
|
X
XMAX
$8.34
|
7.31% | Jun 24 |
NMRK
$15.02
|
1.60% | Jun 24 |
JLL
$299.78
|
4.44% | Jun 24 |
CAG
$13.43
|
4.06% | Jun 23 |
